TABLE 1.
Demographic and baseline characteristics
| NT-814 once-daily dose | |||||
| Characteristic | Placebo N = 18 | 50 mg N = 15 | 100 mg N = 15 | 150 mg N = 15 | 300 mg N = 13 |
| Age (years), mean ± SD | 55.2 ± 4.08 | 55.9 ± 5.57 | 55.3 ± 5.43 | 56.7 ± 4.37 | 53.8 ± 3.88 |
| Race, n (%) | |||||
| White | 16 (88.9) | 11 (73.3) | 11 (73.3) | 13 (86.7) | 11 (84.6) |
| Black or African-American | 2 (11.1) | 4 (26.7) | 4 (26.7) | 2 (13.3) | 2 (15.4) |
| Ethnicity, n (%) | |||||
| Hispanic/Latino | 13 (72.2) | 10 (66.7) | 8 (53.3) | 10 (66.7) | 9 (69.2) |
| Not Hispanic/Latino | 5 (27.8) | 5 (33.3) | 7 (46.7) | 5 (33.3) | 4 (30.8) |
| BMI (kg/m2), mean ± SD | 28.3 ± 3.71 | 27.6 ± 3.15 | 28.0 ± 4.51 | 28.6 ± 3.35 | 28.4 ± 4.28 |
BMI, body mass index; SD, standard deviation.